1. Home
  2. ASTE vs MPLT Comparison

ASTE vs MPLT Comparison

Compare ASTE & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astec Industries Inc.

ASTE

Astec Industries Inc.

HOLD

Current Price

$53.03

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$29.13

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTE
MPLT
Founded
1972
2018
Country
United States
United States
Employees
N/A
133
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
ASTE
MPLT
Price
$53.03
$29.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$66.00
$32.67
AVG Volume (30 Days)
163.9K
255.6K
Earning Date
05-06-2026
05-28-2026
Dividend Yield
0.85%
N/A
EPS Growth
784.21
N/A
EPS
0.06
N/A
Revenue
N/A
N/A
Revenue This Year
$14.72
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$876.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.83
$12.24
52 Week High
$65.69
$33.28

Technical Indicators

Market Signals
Indicator
ASTE
MPLT
Relative Strength Index (RSI) 53.33 52.75
Support Level $50.25 $26.07
Resistance Level $54.17 $31.69
Average True Range (ATR) 2.04 2.47
MACD 0.50 -0.14
Stochastic Oscillator 76.31 68.33

Price Performance

Historical Comparison
ASTE
MPLT

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: